Market Research Logo

Kolon Life Science Inc (102940) - Financial and Strategic SWOT Analysis Review

Kolon Life Science Inc (102940) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Kolon Life Science Inc (KLS) carries out research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, first cell-mediated gene therapy for osteoarthritis. KLS' product portfolio includes biopharmaceuticals, APIs, antimicrobials and water treatment solutions. Its technology platform produces and utilizes protein for human body by performing gene manipulation and cell culturing technology. The company’s cell-mediated gene therapies are used in degenerative diseases. It offers anti-bacterial agents for cosmetic, paint and other industries and water treatment agents. KLS is headquartered in Gwachun-si, Gyunggi-do, South Korea.

Kolon Life Science Inc Key Recent Developments

Dec 20,2016: BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor Use in Invossa Osteoarthritis Cell-Mediated Gene Therapy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Kolon Life Science Inc - Key Facts
Kolon Life Science Inc - Key Employees
Kolon Life Science Inc - Major Products and Services
Kolon Life Science Inc - Pharmaceutical Pipeline Products Data
Kolon Life Science Inc, Pipeline Products by Therapy Area
Kolon Life Science Inc, Pipeline Products by Development Phase
Kolon Life Science Inc - History
Kolon Life Science Inc - Company Statement
Kolon Life Science Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Kolon Life Science Inc - Business Description
Kolon Life Science Inc - SWOT Analysis
SWOT Analysis - Overview
Kolon Life Science Inc - Strengths
Kolon Life Science Inc - Weaknesses
Kolon Life Science Inc - Opportunities
Kolon Life Science Inc - Threats
Kolon Life Science Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kolon Life Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Kolon Life Science Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Kolon Life Science Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 20, 2016: BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor Use in Invossa Osteoarthritis Cell-Mediated Gene Therapy
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tabless
Kolon Life Science Inc, Key Facts
Kolon Life Science Inc, Key Employees
Kolon Life Science Inc, Major Products and Services
Kolon Life Science Inc, Number of Pipeline Products by Therapy Area
Kolon Life Science Inc, Number of Pipeline Products by Development Stage
Kolon Life Science Inc, History
Kolon Life Science Inc, Other Locations
Kolon Life Science Inc, Key Competitors
Kolon Life Science Inc, Ratios based on current share price
Kolon Life Science Inc, Annual Ratios
Kolon Life Science Inc, Annual Ratios (Cont...1)
Kolon Life Science Inc, Annual Ratios (Cont...2)
Kolon Life Science Inc, Interim Ratios
Kolon Life Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Kolon Life Science Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Kolon Life Science Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Kolon Life Science Inc, Pipeline Products by Therapy Area
Kolon Life Science Inc, Pipeline Products by Development Phase
Kolon Life Science Inc, Performance Chart (2012 - 2016)
Kolon Life Science Inc, Ratio Charts
Kolon Life Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Kolon Life Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report